abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

المقال

6 إبريل 2004

الكاتب:
Andrew Balls, Business Day [So. Africa]

Cheaper Drugs for Developing World

An effort to provide cheap generic AIDS drugs to people in poor countries will be extended to the whole of the developing world, under a plan outlined yesterday by the Clinton Foundation and agencies which fund treatment for AIDS...The pharmaceutical manufacturers are Aspen Pharmacare Holdings, of SA, and Cipla, Hetero Drugs, Matrix Laborotories and Ranbaxy Laboratories, of India. Bayer Diagnostics, Beckman Coulter, Becton Dickinson, bioMerieux and Roche Diagnostics will provide the diagnostic tests.